Greetings!
While on one hand the Madras High Court is to hear the case challenging the online sale of medicines through e-pharmacies on November 19th, on the other hand one of India’s largest online e-pharmacy companies has announced the launch of their 2 hour express delivery services to fulfil the acute and immediate requirements of their customers. Read more on this and other interesting articles under Drug laws & Policy Injections and Pharma injections sections respectively.
First line antibiotics are becoming ineffective in treatment of neonates (under-28-day children) suffering from different sorts of bacterial infections, shows a study conducted by doctors. Catch up on this research along with drug haul cases in Jaipur and busting of multi state immunorel injections racket in Mumbai under Drug Dopes section of this issue.
We constantly endeavour not only to collate important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. This issue features a contribution by Dr.Rajini Mathur from Mumbai on the Whatsapp rumor of paralysis cure. Mark your calendar with the interesting upcoming events listed in our newsletter and remember to take your laughter dose in the end.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“India’s bold and ambitious National Health Protection Scheme is a priceless gift to people. This is an investment not only in a healthier future but in a safer future because when people can access health services close to their homes, outbreaks can be prevented and detected early. That’s why we say that UHC and national health security are two sides of the same coin.”
Tedros Adhanom Ghebreyesus
WHO Director General
Public Has Right To Know About Medicines
The Central government has proposed a new grant-in-aid programme to hand-hold healthcare and medical researchers who are keen on commercialising their breakthrough ideas and technologies in the pharmaceutical and medical devices sector. The funding, to be provided for a maximum span of 24 months with an unlimited quantum of budget, would benefit research activity and innovation in the field of drug discovery, biotherapeutics, regenerative medicine, vaccines, clinical trials, medical devices and diagnostics.
US FDA Permits Marketing Of A Diagnostic Test To Aid In The Determination Of Menopausal Status
Maryland, 24 Oct 2018: Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient’s menopausal status.
US Approves First New Type Of Flu Drug In 2 Decades
TRENTON, N.J, 25 OCT 2018: U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season.
US FDA Launches Global Operation To Crack Down On Websites Selling Illegal, Potentially Dangerous Drugs
Maryland, 23 Oct 2018: The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, acted this week to target 465 websites that illegally sell potentially dangerous, unapproved versions of opioid, oncology and antiviral prescription drugs to U.S. consumers.
Pregabalin and gabapentin to be reclassified as Class C controlled substances
Pregabalin and gabapentin are to be reclassified as Class C controlled substances from April 2019, the government has announced. The switch will come more than two years after the Advisory Council on the Misuse of Drugs recommended that the two medicines become controlled drugs and be placed under Schedule 3 of the Misuse of Drugs Regulations 2001 and Class C of the Misuse of Drugs Act 1971.
Missouri Teenager Almost Killed By A Counterfeit Oxycodone Pill Containing Carfentanil
November 9, 2018: The Kansas City Star reported on a guilty plea in U.S. District Court in Kansas City from a man who sold a counterfeit oxycodone pill made with carfentanil that caused a non-fatal overdose in a 17-year-old boy.
Pennsylvania Woman Killed By Counterfeit Fentanyl Pill; Dealer Charged With Her Death
November 8, 2018: A Northampton County grand jury indicted a Pennsylvania man who allegedly sold counterfeit Percocet pills made with fentanyl that killed 27-year-old Kara Heckenberger, according to The Morning Call.
Frequently Asked Questions
Q: Pneumonia: Causes, Symptoms and Treatments
Ans: Pneumonia is an infection of the lungs that is caused by bacteria, viruses, fungi, or parasites. It is characterized primarily by inflammation of the alveoli in the lungs or by alveoli that are filled with fluid (alveoli are microscopic sacs in the lungs that absorb oxygen). At times a very serious condition, pneumonia can make a person very sick or even cause death. Although the disease can occur in young and healthy people, it is most dangerous for older adults, babies, and people with other diseases or impaired immune systems. Read More>>>
WhatsApp Rumour Of ‘Paralysis Cure’ Sends Patients Haring To KEM
Article contributed by Dr.Rajini Mathur, Mumbai
Mumbai, 3 Nov 2018: Viral message claims that a machine procured last month by the hospital can cure paralysis; KEM neurosurgeon clarifies that it can only help patients within the first 24 hours of a stroke and cannot be used to treat old cases.
Avinash Raut, Pharma professionalThe PSM-India’s initiated “The Prescription” newsletter provides beneficial information and a very positive endeavour.
Ms. Lopamudra Dixit, Homemaker: India continues to be among those countries of the world that have a high burden of diseases. Thanks for making us aware of the precautions and happenings around us in the medical field.
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.